ENvue Medical removes Series H Preferred Floor Price in exchange for $2.5M investment

ENvue Medical, Inc.

Entered Amendment Agreement with Required Holders to file Certificate of Amendment removing Floor Price from Series H Convertible Preferred Stock.
In consideration, holders exercised $2,500,000 of Additional Investment Right from July 2025 purchase agreement.
Certificate of Amendment filed and effective January 30, 2026.
The amendment modifies conversion rights of Series H Preferred by eliminating the Floor Price.
Company receives $2.5M new capital from existing preferred holders.

Key facts

Extracted from this filing and checked against the source text.

Equity Issuances SEC 8-K Item 3.02/3.03 confidence 0.9

ENvue Medical, Inc. issued exercising $2,500,000 of the Additional Investment Right of preferred stock to Required Holders for the Required Holders agreed to amend the Certificate of Designations to remove the Floor Price in consideration of the holders of the Preferred Stock exercising.

Security: preferred stock
Shares: exercising $2,500,000 of the Additional Investment Right
Purchaser: Required Holders
Consideration: the Required Holders agreed to amend the Certificate of Designations to remove the Floor Price in consideration of the holders of the Preferred Stock exercising

Exact text from the filing

On January 30, 2026, the Company entered into that certain Amendment Agreement (the " Amendment Agreement ") with the Required Holders (as defined in the Amendment Agreement). Pursuant to the Amendment Agreement, the Required Holders agreed to amend the Certificate of Designations by filing a Certificate of Amendment (the " Certificate of Amendment ") to the Certificate of Designations with the Secretary of State of the State of Delaware to remove the Floor Price (as defined in the Certificate of Designations) in consideration of the holders of the Preferred Stock exercising $2,500,000 of the Additional Investment Right (as such concept is described in the Securities Purchase Agreement by and between the Company and the holders of the Preferred Stock on July 18, 2025, and which such form of Securities Purchase Agreement is filed as Exhibit 10.1 to the Company’s Current Report on Form 8-K filed on July 22, 2025).

View on SEC.gov

Governance Changes SEC 8-K Item 5.03/5.05/5.06 confidence 0.4

ENvue Medical, Inc.: Certificate of Amendment to Articles of Incorporation filed.

Change: charter amendment

Exact text from the filing

matters described in Item 1.01 of this Current Report on Form 8-K related to the filing of the Certificate of Amendment is incorporated herein by reference.

View on SEC.gov

32 equity issuances filed in the last 30 days. Browse all equity issuances →

ENvue Medical, Inc. filing history →

Source: SEC EDGAR

accession 0001493152-26-004523

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.